162 related articles for article (PubMed ID: 30851663)
1. Anti-proliferative and antitumor activity of organotin(IV) compounds. An overview of the last decade and future perspectives.
Banti CN; Hadjikakou SK; Sismanoglu T; Hadjiliadis N
J Inorg Biochem; 2019 May; 194():114-152. PubMed ID: 30851663
[TBL] [Abstract][Full Text] [Related]
2. Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
Sirajuddin M; McKee V; Tariq M; Ali S
Eur J Med Chem; 2018 Jan; 143():1903-1918. PubMed ID: 29133050
[TBL] [Abstract][Full Text] [Related]
3. Syntheses, molecular structures, electrochemical behavior, theoretical study, and antitumor activities of organotin(IV) complexes containing 1-(4-chlorophenyl)-1-cyclopentanecarboxylato ligands.
Shang X; Meng X; Alegria EC; Li Q; Guedes da Silva MF; Kuznetsov ML; Pombeiro AJ
Inorg Chem; 2011 Sep; 50(17):8158-67. PubMed ID: 21793560
[TBL] [Abstract][Full Text] [Related]
4. Organotin (IV) Dithiocarbamate Compounds as Anticancer Agents: A Review of Syntheses and Cytotoxicity Studies.
Abd Aziz NA; Awang N; Chan KM; Kamaludin NF; Mohamad Anuar NN
Molecules; 2023 Aug; 28(15):. PubMed ID: 37570810
[TBL] [Abstract][Full Text] [Related]
5. Recent Advancements in Organotin(IV) Complexes as Potential Anticancer Agents.
Devi J; Yadav J
Anticancer Agents Med Chem; 2018; 18(3):335-353. PubMed ID: 29110624
[TBL] [Abstract][Full Text] [Related]
6. Cell proliferation inhibition and antitumor activity of novel alkyl series of diorganotin(IV) compounds.
Koch B; Baul TS; Chatterjee A
J Appl Toxicol; 2008 May; 28(4):430-8. PubMed ID: 17668440
[TBL] [Abstract][Full Text] [Related]
7. Mode of action of tin-based anti-proliferative agents: Biological studies of organotin(IV) derivatives of fatty acids.
Nath M; Vats M; Roy P
J Photochem Photobiol B; 2015 Jul; 148():88-100. PubMed ID: 25900554
[TBL] [Abstract][Full Text] [Related]
8. Organotin(IV) Carboxylates as Promising Potential Drug Candidates in the Field of Cancer Chemotherapy.
Sirajuddin M; Ali S
Curr Pharm Des; 2016; 22(44):6665-6681. PubMed ID: 27604610
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of new Organotin(IV) anticancer agents and their cytotoxicity profile on HL-60, MCF-7 and HeLa human cancer cell lines.
Ullah H; Previtali V; Mihigo HB; Twamley B; Rauf MK; Javed F; Waseem A; Baker RJ; Rozas I
Eur J Med Chem; 2019 Nov; 181():111544. PubMed ID: 31374420
[TBL] [Abstract][Full Text] [Related]
10. Organotin(IV) Dithiocarbamate Complexes: Chemistry and Biological Activity.
Adeyemi JO; Onwudiwe DC
Molecules; 2018 Oct; 23(10):. PubMed ID: 30304779
[TBL] [Abstract][Full Text] [Related]
11. The triphenyltin(VI) complexes of NSAIDs and derivatives. Synthesis, crystal structure and antiproliferative activity. Potent anticancer agents.
Dokorou V; Primikiri A; Kovala-Demertzi D
J Inorg Biochem; 2011 Feb; 105(2):195-201. PubMed ID: 21194618
[TBL] [Abstract][Full Text] [Related]
12. Organotin(IV) complexes derived from Schiff base N'-[(1E)-(2-hydroxy-3-methoxyphenyl)methylidene]pyridine-4-carbohydrazone: synthesis, in vitro cytotoxicities and DNA/BSA interaction.
Hong M; Geng H; Niu M; Wang F; Li D; Liu J; Yin H
Eur J Med Chem; 2014 Oct; 86():550-61. PubMed ID: 25216377
[TBL] [Abstract][Full Text] [Related]
13. Dibutyltin(IV) Complexes Derived from L-DOPA: Synthesis, Molecular Docking, Cytotoxic and Antifungal Activity.
Rocha-Del Castillo E; Gómez-García O; Andrade-Pavón D; Villa-Tanaca L; Ramírez-Apan T; Nieto-Camacho A; Gómez E
Chem Pharm Bull (Tokyo); 2018; 66(12):1104-1113. PubMed ID: 30504627
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization and in vitro biological evaluation of novel organotin(IV) compounds with derivatives of 2-(5-arylidene-2,4-dioxothiazolidin-3-yl)propanoic acid.
Pantelić NĐ; Zmejkovski BB; Božić B; Dojčinović B; Banjac NR; Wessjohann LA; Kaluđerović GN
J Inorg Biochem; 2020 Oct; 211():111207. PubMed ID: 32801055
[TBL] [Abstract][Full Text] [Related]
15. Amino acetate functionalized Schiff base organotin(IV) complexes as anticancer drugs: synthesis, structural characterization, and in vitro cytotoxicity studies.
Baul TS; Basu S; de Vos D; Linden A
Invest New Drugs; 2009 Oct; 27(5):419-31. PubMed ID: 18941713
[TBL] [Abstract][Full Text] [Related]
16. Potentially bioactive organotin(IV) compounds: synthesis, characterization, in vitro bioactivities and interaction with SS-DNA.
Sirajuddin M; Ali S; McKee V; Sohail M; Pasha H
Eur J Med Chem; 2014 Sep; 84():343-63. PubMed ID: 25036793
[TBL] [Abstract][Full Text] [Related]
17. Chemistry and applications of organotin(IV) complexes of Schiff bases.
Nath M; Saini PK
Dalton Trans; 2011 Jul; 40(27):7077-121. PubMed ID: 21494719
[TBL] [Abstract][Full Text] [Related]
18. Triphenyltin(IV) benzoates with diazenyl/imino scaffold exhibiting remarkable apoptosis mediated by reactive oxygen species.
Basu Baul TS; Dutta D; Duthie A; Prasad R; Rana NK; Koch B; Tiekink ERT
J Inorg Biochem; 2017 Aug; 173():79-92. PubMed ID: 28505480
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of fluorescent pyrrolyldipyrrinato Sn(IV) complexes.
Crawford SM; Al-Sheikh Ali A; Cameron TS; Thompson A
Inorg Chem; 2011 Sep; 50(17):8207-13. PubMed ID: 21786802
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Evaluation of Antiproliferative Properties of Novel Organotin(IV) Carboxylate Compounds with Propanoic Acid Derivatives on a Panel of Human Cancer Cell Lines.
Pantelić NĐ; Božić B; Zmejkovski BB; Banjac NR; Dojčinović B; Wessjohann LA; Kaluđerović GN
Molecules; 2021 May; 26(11):. PubMed ID: 34071809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
